Sandbox Reserved 1490: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->  
{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->  
==Kinase Domain of Tyrosine-protein kinase receptor TIE-2 (PDB:6MWE)==
==Crystal structure of cytoplasmic kinase domain of Tie2 in complex with decipera compound DP1919==
<StructureSection load='6MWE' size='340' side='right' caption='Caption for this structure' scene='' name='pp'>
<StructureSection load='6MWE' size='340' side='right' caption='Caption for this structure' scene='' name='pp'>
The protein we are focusing one is a protein kinase receptor to a family of ligands called angiopoietins. This receptor is a Tyrosine Kinase TIE2. We are going to analyze the kinase domain of this protein
The protein we are focusing one is a protein kinase receptor to a family of ligands called angiopoietins. This receptor is a Tyrosine Kinase TIE2. We are going to analyze the kinase domain of this protein
Line 31: Line 31:
Looking more closely at the TIE2 intracellular domain, 1106 is found at the base of a loop formed between the C-terminus tail and the C-terminus lobe of the kinase. The OH group of Tyr-1106 is thus directly into the solvent and accessible to phosphorylation. However, Tyr-1100 is not solvent exposed : thereby implying that the carboxy-terminal tail must undergo a conformational change upon activation of the receptor to expose this tyrosine residue for phosphorylation.<ref>PMID:12665569</ref>
Looking more closely at the TIE2 intracellular domain, 1106 is found at the base of a loop formed between the C-terminus tail and the C-terminus lobe of the kinase. The OH group of Tyr-1106 is thus directly into the solvent and accessible to phosphorylation. However, Tyr-1100 is not solvent exposed : thereby implying that the carboxy-terminal tail must undergo a conformational change upon activation of the receptor to expose this tyrosine residue for phosphorylation.<ref>PMID:12665569</ref>


Consequent to ANGPT1 stimulation, the SH2 domain-containing p85 subunit of phosphatidylinositol (PI) 3-kinase is recruited to TIE via tyrosine residue 1100 in the C-end tail of the receptor, leading to activation of the enzyme.<ref>PMID:12665569</ref>  
Consequent to ANGPT1 stimulation, the SH2 domain-containing p85 subunit of phosphatidylinositol (PI) 3-kinase [[2pna]] is recruited to TIE via tyrosine residue 1100 in the C-end tail of the receptor, leading to activation of the enzyme.<ref>PMID:12665569</ref>  


Interestingly, inhibition of PI 3′ kinase activity can only partially inhibit the chemotactic effect of ANGPT1 on endothelial cells, thereby implying that additional TIE2 binding partners may also contribute to ANGPT1-mediated endothelial cell migration. Phosphorylation of TIE2 further results in its association with a docking protein related to downstream of kinase (Dok), known as Dok-R, it allows Dok-R to serve as a substrate of TIE2 and thereby become tyrosine phosphorylated.<ref>PMID:12665569</ref>
Interestingly, inhibition of PI 3′ kinase activity can only partially inhibit the chemotactic effect of ANGPT1 on endothelial cells, thereby implying that additional TIE2 binding partners may also contribute to ANGPT1-mediated endothelial cell migration. Phosphorylation of TIE2 further results in its association with a docking protein related to downstream of kinase (Dok), known as Dok-R, it allows Dok-R to serve as a substrate of TIE2 and thereby become tyrosine phosphorylated.<ref>PMID:12665569</ref>
Line 57: Line 57:


====Regions ====
====Regions ====
– Extracellular region : AA 23 to 748 (already found 3D structures)[[2gy5]]
– Extracellular region : AA 23 to 748 (already found 3D structures: [[2gy5]], [[2gy7]], [[4k0v]], [[5mya]], [[5myb]], [[5utk]])


– Transmembrane region : AA 749 to 769
– Transmembrane region : AA 749 to 769


– Cytoplasmic region : AA 770 to 1124
– Cytoplasmic region : AA 770 to 1124 (already found 3D structures: [[1fvr]], [[2oo8]], [[2osc]], [[2wqb]], [[3bea]], [[3l8p]], [[4x3j]]


====Domains ====  
====Domains ====  

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA, Laurie Lacombe